Incyte Corp
(INCY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | INCY | GMAB | ROIV | ||
| Company | Incyte Corp | Genmab A/S ADR | Roivant Sciences Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 98.52 | 30.42 | 27.60 | ||
| High | 99.79 | 30.42 | 27.70 | ||
| Low | 97.44 | 29.67 | 26.35 | ||
| Latest | 98.84 | 30.06 | 26.80 | ||
| Change | -1.21 | -0.54 | -0.55 | ||
| % Change | -1.21% | -1.76% | -2.01% | ||
| Volume | 1,905,582 | 1,377,010 | 5,359,377 | ||
| 20-Day Average Volume | 1,973,394 | 1,841,826 | 7,022,089 | ||
| Previous Close | 100.05 | 30.60 | 27.35 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 103.27 | 32.55 | 23.34 | ||
| 20-Day Raw Stochastic | 11.63% | 6.77% | 83.62% | ||
| 20-Day Relative Strength | 45.51 | 41.11 | 68.00 | ||
| Weighted Alpha | +42.52 | +39.58 | +182.07 | ||
| Today's Opinion | 64% Buy | 40% Buy | 100% Buy | ||
| Previous Opinion | 64% Buy | 40% Buy | 100% Buy | ||
| Last Month's Opinion | 88% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.66% since 02/04/26 | -5.77% since 02/04/26 | +23.79% since 02/04/26 | ||
| Low | 97.44 on 02/11/26 | 29.67 on 02/11/26 | 20.99 on 02/05/26 | ||
| High | 109.48 on 02/09/26 | 32.04 on 02/05/26 | 27.94 on 02/10/26 | ||
| 1-Month | |||||
| %Chg | -7.51% since 01/09/26 | -12.26% since 01/09/26 | +21.93% since 01/09/26 | ||
| Low | 97.44 on 02/11/26 | 29.67 on 02/11/26 | 20.98 on 02/02/26 | ||
| High | 109.48 on 02/09/26 | 35.43 on 01/14/26 | 27.94 on 02/10/26 | ||
| 3-Month | |||||
| %Chg | -8.62% since 11/11/25 | -0.82% since 11/11/25 | +28.23% since 11/11/25 | ||
| Low | 93.54 on 12/12/25 | 29.67 on 02/11/26 | 19.96 on 12/02/25 | ||
| High | 112.29 on 01/07/26 | 35.43 on 01/14/26 | 27.94 on 02/10/26 | ||
| 6-Month | |||||
| %Chg | +24.81% since 08/11/25 | +42.60% since 08/11/25 | +139.93% since 08/11/25 | ||
| Low | 79.33 on 08/12/25 | 21.17 on 08/12/25 | 11.24 on 08/12/25 | ||
| High | 112.29 on 01/07/26 | 35.43 on 01/14/26 | 27.94 on 02/10/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 19,642,116 | 19,656,950 | 19,021,706 | ||
| Shares Outstanding, K | 196,323 | 642,384 | 695,492 | ||
| Annual Sales | 4,241,220,000 | 3,121,270,000 | 29,050,000 | ||
| Annual Net Income | 32,610,000 | 1,137,380,000 | -171,980,000 | ||
| Last Quarter Sales | 1,365,980,000 | 1,022,000,000 | 2,000,000 | ||
| Last Quarter Net Income | 424,170,000 | 401,000,000 | -265,890,000 | ||
| 60-Month Beta | 0.82 | 0.90 | 1.22 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.80 on 02/10/26 | 0.65 on 11/06/25 | -0.38 on 02/06/26 | ||
| Latest Earnings Date | 02/10/26 | 02/17/26 | 06/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 20.49 | 14.91 | 0.00 | ||